Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tang-min-ling Pills in Type 2 Diabetes (Liver-Stomach Heat Retention Syndrome)
NCT01087242Phase 3Unknown
- Sponsor
- Guang'anmen Hospital
- Start
- May 2009
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tangminling in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Guang'anmen Hospital. Primary endpoint: Glycosylated Hemoglobin at 12 weeks. Status: unknown.
02
Drugs
tangminling
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01087242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01087242.